Search Results 21-30 of 17128 for GnRH
Use of GnRH agonists (1 month depot) or intrauterine device within 3 months of the start of run-in. Use of GnRH antagonist, combined oral contraceptive pill ...
* Prior use of gonadotropin releasing hormone (GnRH) analogues during puberty * Coronary artery disease or heart failure. * A known medical condition that ...
You should also receive a gonadotropin-releasing hormone (GnRH) analog treatment or have had a surgery to lower testosterone in your body (surgical castration) ...
The use of GnRH analogs to achieve post menopausal status is not allowed. Prior treatment: No prior surgical excision in the index breast for current DCIS ...
For instance, gonadotropin-releasing hormone (GnRH) agonists resulted in side effects such as bone loss and hot flashes, which restricted their use to 3 to 6 ...
Use of any drug that can affect estrogen production or signaling (e.g., GnRH agonists and antagonists, estrogen receptor modulators, etc.). Use of systemic ...
Premenopausal patients being treated with GNRH agonist/antagonist to induce menopause are eligible 2. Patients who received treatment with CDK 4/6 ...
Current use of GnRH agonists or antagonists, or contraceptive steroids; MRI suggestive of malignant disease of uterus, ovary, or cervix; Hypersensitivity to ...
Gonadotropin-releasing hormone agonists (GnRH-a), medications that turn off the ovaries' production of hormones, which reduces menstrual bleeding and causes ...
Radiologists at Mayo Clinic were instrumental in developing novel bowel imaging techniques, including magnetic resonance (MR) and CT enterography. Current ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.